We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

UBS analyst Matthew Weston maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £115.00. The company’s shares opened today at p11,364.00.

CHICAGO, Feb. 25, 2025 /PRNewswire/ -- SPINS, the leading provider of data and intelligence for the natural products industry, has announced a strategic partnership with Stackline, the leading ...

A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs (shareholders) alleged that they bought AstraZeneca American Depositary ...

AstraZeneca PLC (LON:AZN) announced a healthy earnings result recently, and the market rewarded it with a strong uplift in the stock price. This reaction by the market reaction is understandable ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase “defensive ...

Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the April 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best global stocks to buy according to hedge funds. The United States has long been a magnet ...

In early trading on Thursday, shares of AstraZeneca topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.4%. Year to date, AstraZeneca registers a 13.0% ...

Shares of AZN opened at $73.58 on Friday. The company has a quick ratio of 0.71, a current ratio of 0.93 and a debt-to-equity ratio of 0.71. AstraZeneca has a 52-week low of $61.77 and a 52-week ...